Home Musculoskeletal Disorders

Musculoskeletal Disorders

Latest
Musculoskeletal Disorders

Capricor Axes About Half Its Workforce, Resumes Dosing in Trial of...

Gut microbiome
Musculoskeletal Disorders

Antibiotic-Related Microbiome Disruption Impacts on Skeletal Development

Musculoskeletal Disorders

Motor Function Decline and Lifespan in Worms Impacted by Single Protein

Osteoporosis
Musculoskeletal Disorders

Hundreds of Genetic Influences on Osteoporosis Identified

Musculoskeletal Disorders

Fluorescent Muscular Dystrophy Mouse Lights Up Potential Antisense Oligo Drugs

Smooth muscle tissue
Musculoskeletal Disorders

Breast Cancer Drug Slows Progress of Fatal Muscle Disorder

Amyloid/Muscle
Musculoskeletal Disorders

Amyloids Shown to Also Play Beneficial Role in Developing Healthy Muscle...

Source: Wellcome Images
Musculoskeletal Disorders

Brown Fat Flexes Its Muscle

A month after releasing preliminary positive results from a Phase I/IIa trial of its Duchenne Muscular Dystrophy (DMD) gene therapy candidate AAVrh74.MHCK7.micro-Dystrophin (pictured)
Musculoskeletal Disorders

FDA Places Clinical Hold on Sarepta DMD Micro-Dystrophin Gene Therapy Trial

Benitec Biopharma could generate up to $655 million-plus in payments from licensing its preclinical gene therapy for oculopharyngeal muscular dystrophy (OPMD; pictured)
Musculoskeletal Disorders

Axovant Licenses Benitec Gene Therapy Candidates for OPMD, Neurological Disorders

Load more

Recently Featured

Stay Connected

556,577FansLike
47,437FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up